1 year return (CAGR)
90.56%
Intra-Cellular Therapies Inc Exchange (NASDAQ, USD)
ITCI
-
-0.05 (-0.04%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
29.46%
5 year return (CAGR)
53.39%
10 year return (CAGR)
17.34%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
14.05B
Price/Sales
22.92
Ent value
13.76B
Price/Book
12.27
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
42.18
EPS growth
-12.47%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 131.90 |
| Daily high | 131.98 |
| Daily low | 131.63 |
| Daily Volume | 16.0M |
| 1y analyst estimate | 132.00 |
| Beta | 0.46 |
| EPS (TTM) | -0.82 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ITCI | S&P500 | |
| Current price drop from All-time high | -0.04% | -8.48% |
| Highest price drop | -87.64% | -56.47% |
| Date of highest drop | 1 Oct 2019 | 9 Mar 2009 |
| Avg drop from high | -39.32% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 1585 days | 1805 days |
News
No items found